PB1964: COMPARISON OF CLINICO-HEMATOLOGICAL PARAMETERS AND MOLECULAR AND CYTOGENETIC RESPONSE OF TWO BCR-ABL FUSION TRANSCRIPTS IN CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB

por Baraa, Laabidi, Nader, Slama, Ines, Ouahchi, Boufrikha, Wiem, Laatiri, Adnene
Publicado 2023

PB2250: THE IMPACT OF JAK2V617F MUTATION POSITIVITY IN ESSENTIAL THROMBOCYTHEMIA:ABOUT 74 CASES.

por Cheffai, Arij, Nader, Slama, Ines, Ouahchi, Boufrikha, Wiem, Baraa, Laabidi, Boukhriss, Sarra, Laatiri, Adnene
Publicado 2023

PB2241: THE VASCULAR RISK OF ESSENTIAL THROMBOCYTHEMIA AND RELIABILITY OF THROMBOTIC RISK ASSESSMENT SCORES

por Cheffai, Arij, Nader, Slama, Ines, Ouahchi, Baraa, Laabidi, Boufrikha, Wiem, Boukhriss, Sarra, Laatiri, Adnene
Publicado 2023

PB2262: PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED/REFRACTORY HODGKINN LYMPHOMA

por Zahra, Kmira, Sghaier, Rihab Ben, Guermazi, Monia, Sayed, Nesrine Ben, Ines, Ouahchi, Zaier, Monia, Youssef, Yosra Ben, Regaieg, Haifa, Khelif, Abderrahim
Publicado 2023

PB2556: MEGALOBLASTIC ANEMIA: EPIDEMIOLOGICAL, CLINICAL, AND ETIOLOGICAL PROFILE: ABOUT 200 CASES.

por Zahra, Kmira, Hasnaoui, Zeineb, Chenbah, Wafa, Ncibi, Seif, Ines, Ouahchi, Sayed, Nesrine Ben, Zaier, Monia, Youssef, Yosra Ben, Regaieg, Haifa, Khelif, Abderrahim
Publicado 2023